USMLE Step 1 & 2 Pneumonia and Tuberculosis

Last updated: May 2, 2026

Pneumonia and Tuberculosis questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.

The rule

Lower respiratory tract infection workup turns on three questions: where did the patient acquire it (community vs hospital vs aspiration), what host factors point to a specific organism (age, comorbidities, exposures, immune status), and is this an acute pyogenic process or a subacute granulomatous one (TB, fungal, atypical). The combination of clinical setting + chest imaging pattern + sputum microbiology drives empiric therapy. For tuberculosis specifically, you must separate latent infection (positive IGRA/PPD, normal CXR, asymptomatic — treat to prevent reactivation) from active disease (symptoms + CXR findings + AFB smear/NAAT/culture — treat with RIPE and report to public health).

Elements breakdown

Community-Acquired Pneumonia (CAP) — typical

Acute pyogenic infection acquired outside healthcare in a previously well or chronically ill outpatient.

  • Lobar consolidation on CXR
  • Productive cough, fever, pleuritic chest pain
  • Sputum Gram stain shows predominant organism
  • Responds to beta-lactam ± macrolide

Common examples:

  • Streptococcus pneumoniae (most common)
  • Haemophilus influenzae (COPD)
  • Moraxella catarrhalis (COPD, elderly)

CAP — atypical

Subacute pneumonia with extrapulmonary features and a CXR worse than the exam suggests.

  • Dry cough, low-grade fever, malaise
  • Patchy interstitial infiltrates, no consolidation
  • Sputum Gram stain unrevealing
  • Treated with macrolide, doxycycline, or fluoroquinolone

Common examples:

  • Mycoplasma pneumoniae (young adults, cold agglutinins, bullous myringitis)
  • Chlamydia pneumoniae
  • Legionella (water exposure, hyponatremia, diarrhea)
  • Viral (influenza, RSV, SARS-CoV-2)

Hospital-Acquired & Ventilator-Associated Pneumonia

Pneumonia developing >48 hours after admission or intubation.

  • New infiltrate + fever + leukocytosis + purulent secretions
  • Resistant gram-negative and MRSA risk
  • Empiric anti-pseudomonal beta-lactam + MRSA coverage
  • De-escalate based on cultures

Common examples:

  • Pseudomonas aeruginosa
  • MRSA
  • Klebsiella, Acinetobacter, Enterobacter

Aspiration Pneumonia

Pneumonitis or infection from inhaled oropharyngeal or gastric contents in patients with impaired airway protection.

  • Risk: stroke, dementia, alcohol use, seizure, intubation
  • Right lower lobe (upright) or right upper lobe (recumbent) infiltrate
  • Foul-smelling sputum if anaerobic abscess develops
  • Treat with ampicillin-sulbactam or amoxicillin-clavulanate

Common examples:

  • Oral anaerobes
  • Mixed flora with strep species

Latent Tuberculosis Infection (LTBI)

Asymptomatic infection with viable M. tuberculosis contained by host immunity, with no radiographic active disease.

  • Positive IGRA or tuberculin skin test (cutoff varies by risk)
  • Normal or only old fibrotic changes on CXR
  • Asymptomatic, AFB smear/culture negative
  • Treat with isoniazid + rifapentine x12 wk, rifampin x4 mo, or INH x6-9 mo

Active Pulmonary Tuberculosis

Symptomatic infection with replicating M. tuberculosis and radiographic/microbiologic evidence of disease.

  • Cough >3 wk, weight loss, night sweats, hemoptysis
  • Upper-lobe cavitation (reactivation) or middle/lower zone consolidation with hilar adenopathy (primary)
  • AFB smear, NAAT, and culture on three sputum samples; airborne isolation
  • RIPE x2 mo, then INH + rifampin x4 mo; report to public health

Special Hosts

Immunocompromise reshapes the differential and the imaging pattern.

  • HIV with CD4 <200: PCP (Pneumocystis jirovecii), bilateral interstitial, elevated LDH
  • HIV with CD4 <50: MAC, CMV, disseminated fungal
  • Neutropenia: Aspergillus (halo sign, galactomannan)
  • Post-influenza: secondary S. aureus or pneumococcal pneumonia

Common patterns and traps

The Buzzword-to-Bug Map

USMLE pneumonia items are seeded with classic exposure clues that map one-to-one to organisms. Cooling-tower or cruise-ship water with hyponatremia and diarrhea is Legionella; college dormitory with cold agglutinins is Mycoplasma; cavitary upper-lobe disease with night sweats is reactivation TB; bird or bat exposure with mediastinal adenopathy is Histoplasma; post-influenza rapid deterioration with cavitary infiltrates is S. aureus. Memorizing these pairs is the fastest path to the right empiric therapy.

A vignette includes one or two highly specific environmental or epidemiologic clues that point to a single organism even before the answer choices appear.

The Latent-vs-Active TB Trap

The stem describes a positive PPD or IGRA and asks for the next best step. If the patient is asymptomatic with a normal CXR, the answer is treat for latent TB (INH-rifapentine, rifampin, or INH monotherapy). If there are constitutional symptoms or an abnormal CXR, the next step is sputum AFB smears, NAAT, culture, and airborne isolation — not starting RIPE blindly and not skipping the CXR.

A wrong answer offers RIPE therapy for an asymptomatic patient with a positive IGRA, or single-drug INH for a patient with cavitary disease.

The HCAP/VAP Spectrum-Creep Trap

Patients who develop pneumonia >48 hours into admission, or who are intubated, need empiric coverage for Pseudomonas and MRSA — typically vancomycin plus an anti-pseudomonal beta-lactam such as cefepime or piperacillin-tazobactam. Picking standard outpatient CAP regimens (ceftriaxone + azithromycin) for these patients leaves resistant organisms uncovered. The reverse trap is over-treating clear outpatient CAP with vancomycin and cefepime, exposing the patient to nephrotoxicity for no benefit.

A wrong choice offers ceftriaxone plus azithromycin for a ventilated ICU patient, or vancomycin plus cefepime for a healthy outpatient with lobar CAP.

The Aspiration Pattern

Patients with impaired airway protection — stroke, advanced dementia, alcohol intoxication, post-seizure, recent intubation — develop infiltrates in gravity-dependent segments. Right lower lobe is classic for upright aspiration; right upper lobe or superior segment of right lower lobe for recumbent aspiration. Anaerobic involvement produces foul-smelling sputum and may progress to lung abscess; first-line therapy is ampicillin-sulbactam or amoxicillin-clavulanate, not clindamycin (now second-line due to C. difficile risk).

The vignette describes a nursing home resident or post-stroke patient with a right lower lobe infiltrate, and the answer choices include both standard CAP coverage and an aspiration-appropriate beta-lactam/beta-lactamase inhibitor.

The Immunocompromised Pneumonia Differential

In HIV with CD4 <200, bilateral interstitial infiltrates with elevated LDH and exertional desaturation point to Pneumocystis jirovecii pneumonia (PCP), treated with TMP-SMX plus steroids if PaO2 <70 or A-a gradient >35. In neutropenic patients, a halo sign on CT and positive serum galactomannan suggest invasive Aspergillus, treated with voriconazole. Picking standard CAP coverage for these hosts misses the diagnosis entirely.

A wrong answer offers ceftriaxone plus azithromycin for a patient with HIV and a CD4 count of 80 with bilateral interstitial infiltrates and LDH 480.

How it works

Picture Mr. Alvarez, a 64-year-old smoker with COPD who arrives with three days of fever, productive cough, and right-sided pleuritic pain; his CXR shows a right lower lobe consolidation. The setting (outpatient onset), the demographics (older smoker), and the lobar pattern direct you to typical CAP, with S. pneumoniae as the leading organism and H. influenzae a strong second; you start ceftriaxone plus azithromycin. Now flip one variable: change the cough to six weeks, add 12 lb weight loss and drenching night sweats, and put an apical cavitary lesion on the CXR — you have shifted from pyogenic CAP to active TB, and the next best step is airborne isolation plus three sputum AFB smears with NAAT, not broad-spectrum antibiotics. Flip another variable: keep the symptoms acute but make the patient a 22-year-old college student with a low-grade fever, dry cough, and patchy bilateral infiltrates worse than her exam — atypical CAP, almost certainly Mycoplasma, treated with a macrolide. The framework holds: setting + host + radiographic pattern narrows the organism before any culture returns.

Worked examples

Worked Example 1

Which of the following is the most appropriate empiric antibiotic regimen?

  • A Ceftriaxone plus azithromycin ✓ Correct
  • B Vancomycin plus piperacillin-tazobactam
  • C Trimethoprim-sulfamethoxazole plus prednisone
  • D Isoniazid, rifampin, pyrazinamide, and ethambutol

Why A is correct: This is community-acquired pneumonia in a non-ICU inpatient: lobar consolidation, rusty sputum, and a host with COPD all point to Streptococcus pneumoniae as the leading pathogen, with Haemophilus influenzae and atypicals (Mycoplasma, Chlamydia, Legionella) as secondary considerations. Guideline-concordant empiric therapy for hospitalized non-ICU CAP is a beta-lactam (ceftriaxone or ampicillin-sulbactam) plus a macrolide (azithromycin) for atypical coverage, or monotherapy with a respiratory fluoroquinolone.

Why each wrong choice fails:

  • B: Vancomycin plus piperacillin-tazobactam covers MRSA and Pseudomonas, which is appropriate for hospital-acquired or ventilator-associated pneumonia. This patient developed symptoms in the community before any healthcare exposure, so this regimen is excessive and exposes him to nephrotoxicity for no added benefit. (The HCAP/VAP Spectrum-Creep Trap)
  • C: TMP-SMX plus steroids treats Pneumocystis jirovecii pneumonia, which presents in immunocompromised hosts (especially HIV with CD4 <200) with bilateral interstitial infiltrates and elevated LDH — not lobar consolidation in an immunocompetent smoker. (The Immunocompromised Pneumonia Differential)
  • D: RIPE therapy treats active pulmonary tuberculosis, which presents subacutely with weeks of cough, weight loss, and night sweats, and shows upper-lobe cavitation rather than acute lower-lobe consolidation. Starting RIPE without sputum AFB confirmation in a patient with classic bacterial CAP is wrong. (The Latent-vs-Active TB Trap)
Worked Example 2

Which of the following is the most appropriate next step in management?

  • A Initiate isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, then isoniazid and rifampin for 4 months
  • B No treatment is needed because the IGRA is falsely positive due to prior BCG vaccination
  • C Initiate isoniazid plus rifapentine weekly for 12 weeks ✓ Correct
  • D Obtain three sputum samples for AFB smear, NAAT, and culture, and place in airborne isolation

Why C is correct: This patient has latent tuberculosis infection: a positive IGRA (which, unlike the tuberculin skin test, is not affected by prior BCG vaccination), no symptoms, and a normal chest radiograph. Treatment is indicated to prevent reactivation, especially in a healthcare worker. Current preferred regimens for LTBI are isoniazid plus rifapentine weekly for 12 weeks (3HP), rifampin daily for 4 months, or isoniazid daily for 6-9 months — all shorter and better tolerated than full RIPE.

Why each wrong choice fails:

  • A: RIPE therapy is for active tuberculosis disease, not latent infection. Giving four-drug therapy to an asymptomatic patient with a normal CXR overtreats LTBI and exposes her unnecessarily to pyrazinamide hepatotoxicity and ethambutol optic neuritis. (The Latent-vs-Active TB Trap)
  • B: This is a common misconception. The IGRA measures interferon-gamma release in response to M. tuberculosis-specific antigens (ESAT-6, CFP-10) that are absent from BCG, so prior BCG vaccination does not cause a false-positive IGRA. (It can cause false-positive PPDs, which is why IGRA is preferred in BCG-vaccinated patients.) (The Buzzword-to-Bug Map)
  • D: AFB sputum testing and airborne isolation are warranted for suspected active TB — patients with cough, weight loss, night sweats, or an abnormal CXR. This asymptomatic patient with a normal CXR has latent infection, not active disease, and does not need isolation or sputum studies. (The Latent-vs-Active TB Trap)
Worked Example 3

Which of the following is the most likely causative organism?

  • A Streptococcus pneumoniae
  • B Mycoplasma pneumoniae
  • C Legionella pneumophila ✓ Correct
  • D Mycobacterium tuberculosis

Why C is correct: The constellation of pneumonia plus extrapulmonary features — hyponatremia, transaminitis, diarrhea, confusion, and relative bradycardia — in a patient with recent exposure to aerosolized water (hotel hot tub) is the classic Legionella pneumophila vignette. Sputum Gram stain typically shows neutrophils without visible organisms because Legionella is intracellular and stains poorly. Diagnosis is confirmed with urinary antigen (for serogroup 1) or culture on buffered charcoal yeast extract; treatment is a respiratory fluoroquinolone or azithromycin.

Why each wrong choice fails:

  • A: S. pneumoniae is the most common cause of CAP overall and would be a reasonable first guess, but it typically produces lobar consolidation with rusty sputum and Gram-positive diplococci visible on Gram stain. It does not characteristically cause hyponatremia, transaminitis, diarrhea, or relative bradycardia. (The Buzzword-to-Bug Map)
  • B: Mycoplasma can cause an atypical pneumonia with patchy infiltrates and dry cough, but the classic demographic is young adults in close quarters (college dorms, military barracks), and the extrapulmonary signature is cold agglutinin hemolysis, bullous myringitis, and erythema multiforme — not hyponatremia, transaminitis, and diarrhea. (The Buzzword-to-Bug Map)
  • D: Active pulmonary tuberculosis presents subacutely over weeks to months with cough, weight loss, night sweats, and either upper-lobe cavitation (reactivation) or hilar adenopathy with middle-lobe consolidation (primary). The five-day acute febrile course with diarrhea and hyponatremia after hot-tub exposure does not fit TB. (The Latent-vs-Active TB Trap)

Memory aid

For TB reactivation think 'Cough, Cachexia, Cavitation, Contacts' — the 4 C's. For pneumonia organism guessing use SHARP: Setting (CAP/HCAP/aspiration), Host (age, comorbid, immune), Acuity, Radiograph pattern, Predisposing exposure.

Key distinction

Latent TB vs active TB: both have positive IGRA/PPD, but only active TB has symptoms, an abnormal CXR consistent with disease, and positive AFB smear/NAAT/culture — and only active TB requires airborne isolation, RIPE therapy, and public-health reporting.

Summary

Match the clinical setting and host to the likely organism, read the CXR pattern (lobar vs interstitial vs cavitary), and always separate latent from active TB before choosing therapy.

Practice pneumonia and tuberculosis adaptively

Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.

Start your free 7-day trial

Frequently asked questions

What is pneumonia and tuberculosis on the USMLE Step 1 & 2?

Lower respiratory tract infection workup turns on three questions: where did the patient acquire it (community vs hospital vs aspiration), what host factors point to a specific organism (age, comorbidities, exposures, immune status), and is this an acute pyogenic process or a subacute granulomatous one (TB, fungal, atypical). The combination of clinical setting + chest imaging pattern + sputum microbiology drives empiric therapy. For tuberculosis specifically, you must separate latent infection (positive IGRA/PPD, normal CXR, asymptomatic — treat to prevent reactivation) from active disease (symptoms + CXR findings + AFB smear/NAAT/culture — treat with RIPE and report to public health).

How do I practice pneumonia and tuberculosis questions?

The fastest way to improve on pneumonia and tuberculosis is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.

What's the most important distinction to remember for pneumonia and tuberculosis?

Latent TB vs active TB: both have positive IGRA/PPD, but only active TB has symptoms, an abnormal CXR consistent with disease, and positive AFB smear/NAAT/culture — and only active TB requires airborne isolation, RIPE therapy, and public-health reporting.

Is there a memory aid for pneumonia and tuberculosis questions?

For TB reactivation think 'Cough, Cachexia, Cavitation, Contacts' — the 4 C's. For pneumonia organism guessing use SHARP: Setting (CAP/HCAP/aspiration), Host (age, comorbid, immune), Acuity, Radiograph pattern, Predisposing exposure.

What's a common trap on pneumonia and tuberculosis questions?

Treating cavitary apical disease as bacterial CAP and missing TB isolation

What's a common trap on pneumonia and tuberculosis questions?

Confusing latent TB (treat to prevent) with active TB (treat plus isolate plus report)

Related USMLE Step 1 & 2 sub-topics

Ready to drill these patterns?

Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more pneumonia and tuberculosis questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.

Start your free 7-day trial